Participated · Equity · Sep 2025

Alchemy develops advanced materials through a proprietary nanotechnology platform designed to enhance performance and safety across multiple industries. Its flagship products include ExoShield ULTRA, a windshield protection film aimed at the automotive market, and Crypsis Class, a thermal camouflage solution for defence customers. The company’s technology suite focuses on protective films, specialized coatings, and next-generation camouflage materials. Led by CEO Khanjan Desai, Alchemy plans to accelerate product development and commercialization with its newly secured capital. The funds will also be used to expand its manufacturing footprint within Canada, underscoring its commitment to domestic production capabilities. In addition, the company seeks to foster international partnerships with allied nations to broaden its market reach. While financial metrics such as revenue or user counts were not disclosed, the recent financing suggests growing investor confidence in its nanotechnology platform.

Participated · Equity · Jun 2021

Enedym is a technology spin-out from McMaster University that designs and manufactures switched reluctance motors (SRMs), electric powertrains, and advanced control systems. Its patented SRM technology delivers quiet, efficient, and scalable performance while using no permanent magnets or rare-earth metals, tackling both cost and environmental concerns common in today’s electric propulsion systems. The company holds ownership of more than 70 patents and pending patent applications originating from the research of Canada Excellence Research Chair Laureate Dr. Ali Emadi and his team at McMaster Automotive Resource Centre. Enedym also offers a proprietary digitization platform that dramatically shortens motor-design timelines and reduces associated costs. Headquartered at McMaster Innovation Park in Hamilton, Ontario, the startup aims to lower the total cost of electrified powertrains and accelerate global electrification across multiple motor markets. The recent strategic investment from Honda underscores industry confidence in Enedym’s rare-earth-free SRM technology and will fund further product development and operational scaling. No revenue or user metrics have been disclosed to date.

Participated · Series A · Jul 2015

Perimeter Medical Imaging develops, patents, and commercializes high-resolution intraoperative imaging tools to allow clinicians to assess microscopic tissue structures during surgery. Its flagship OTIS™ (Optical Tissue Imaging System) provides an ultra-high resolution image of the entire surface of excised tissue, enabling real-time decisions at the surgical margin. OTIS™ is a platform technology designed to image multiple tissue types and aims to reduce follow-on surgeries—for example, roughly 25% of breast lumpectomy patients currently require a second operation due to residual cancer cells. Perimeter is a privately owned Canadian company and describes OTIS™ as an investigational device limited to investigational use under U.S. law. The company recently closed an oversubscribed $5 million Series A and will use proceeds to complete a clinical study at Princess Margaret Cancer Centre, advance product development, and pursue FDA regulatory clearance for its first tissue-imaging product.